Matthew Plavan
2014 - Cesca Therapeutics
In 2014, Matthew Plavan earned a total compensation of $1M as CEO thru October 28, at Cesca Therapeutics, a 155% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $122,000 |
| Salary | $349,000 |
| Stock Awards | $458,000 |
| Total | $1,029,000 |
Plavan received $458K in stock awards, accounting for 45% of the total pay in 2014.
Plavan also received $100K in bonus, $122K in option awards and $349K in salary.
Rankings
In 2014, Matthew Plavan's compensation ranked 7,481st out of 13,032 executives tracked by ExecPay. In other words, Plavan earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,481 out of 13,032 | 43rd |
Division Manufacturing | 2,760 out of 4,965 | 44th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 349 out of 731 | 52nd |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 107 out of 219 | 51st |
Industry Laboratory Apparatus and Furniture | 1 out of 13 | 92nd |
Source: SEC filing on January 14, 2016.
Plavan's colleagues
We found eight more compensation records of executives who worked with Matthew Plavan at Cesca Therapeutics in 2014.
2014
Hal Baker
Cesca Therapeutics
Former V.P., Commercial Operations & Marketing
2014
October Bessey
Cesca Therapeutics
Chief Financial Officer
2014
Dan Bessey
Cesca Therapeutics
Chief Financial Officer
2014
Ken Harris
Cesca Therapeutics
President thru September 28,
2014
Ken Pappa
Cesca Therapeutics
V.P., Manufacturing and IT
2014
Mitchel Sivilotti
Cesca Therapeutics
Chief Biologist thru December 14,
2014
Michael Bruch
Cesca Therapeutics
Chief Financial Officer
2014
Ray DeGrella
Cesca Therapeutics
VP, Quality & Regulatory Affairs thru September 10,
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019